Who
William Robert Elder
CFO, GC & Secretary
Company insider
Files Form 4 as: CFO, GC & Secretary, CervoMed.
In numbers
- Trades disclosed
- 19
- Buys
- 7
- Sells
- 0
- Bought
- $119K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Sep 2020
- Last trade
- 11 Feb 2026
- Last filed
- 13 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Feb 2026filed 13 Feb 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 18 Nov 2025filed 19 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $21K2,500 at $8.32 | filing |
| 17 Nov 2025filed 19 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $8,4501,000 at $8.45 | filing |
| 12 Nov 2025filed 13 Nov 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $26K3,500 at $7.44 | filing |
| 14 May 2025filed 14 May 2025 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $36K4,233 at $8.46 | filing |
| 4 Feb 2025filed 14 Feb 2025 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 27 Aug 2024filed 27 Aug 2024 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $18K1,000 at $18.16 | filing |
| 26 Jan 2024filed 26 Jan 2024 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 15 Sep 2023filed 15 Sep 2023 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 18 Apr 2022filed 19 Apr 2022 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code C | $2,500100 at $25.00 | filing |
| 18 Apr 2022filed 19 Apr 2022 | CRVO CervoMedBiotechnology | SEC FORM 4 Code C | $2,500100 at $25.00 | filing |
| 18 Mar 2022filed 22 Mar 2022 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code P | $2,5005,000 at $0.50 | filing |
| 27 Jan 2022filed 31 Jan 2022 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —305,743 at $0.00 | filing |
| 1 Mar 2021filed 4 Mar 2021 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —87,684 at $0.00 | filing |
| 1 Mar 2021filed 4 Mar 2021 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —62,522 at $0.00 | filing |
| 17 Nov 2020filed 18 Nov 2020 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $3,1505,000 at $0.63 | filing |
| 16 Nov 2020filed 18 Nov 2020 | CRVO CervoMedBiotechnology | SEC FORM 4 Bought | $6,70010,000 at $0.67 | filing |
| 22 Sep 2020filed 14 Oct 2020 | CRVO CervoMedoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.